Showing 1,361 - 1,380 results of 31,232 for search '(( 5 ((wt decrease) OR (nn decrease)) ) OR ( 50 ((ng decrease) OR (a decrease)) ))', query time: 0.85s Refine Results
  1. 1361
  2. 1362
  3. 1363
  4. 1364

    Supplementary Material for: Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease by Watanabe N. (4118812)

    Published 2020
    “…Of the 27 patients with elevated hsTnI (≥5.0 pg/mL), the hsTnI level was normalized in 20 patients within a year. …”
  5. 1365
  6. 1366

    Loss of FlnA and Fmn2 leads to a defect in cell proliferation along the ventral thoracic wall. by Gewei Lian (523268)

    Published 2017
    “…</b> The number of BrdU or Ki67 positive cells in the ventral midline of null FlnA and null FlnA+Fmn2 embryos was decreased by more than 50% in comparison with those in WT embryo (WT vs null FlnA *** = p <0.0002, WT vs null FlnA+Fmn2 *** = p <0.0008). …”
  7. 1367

    Diabetic kidney shows decreased klotho expression. by Jeong Suk Kang (7359572)

    Published 2021
    “…<p>(a) Representative images of the kidney from normal and diabetic biopsies showing the decreased klotho expression in diabetic podocytes by IHC. …”
  8. 1368
  9. 1369
  10. 1370
  11. 1371
  12. 1372
  13. 1373
  14. 1374
  15. 1375
  16. 1376
  17. 1377

    In vivo analysis of the δ-GABA<sub>A</sub>-Rs in the cerebellar granule layer in WT and TTR-/- mice. by Li Zhou (54356)

    Published 2019
    “…The total δ protein level showed no difference, while the biotinylated surface δ protein level decreased significantly in TTR-/- mice. Both total and the surface γ2 GABA<sub>A</sub>-Rs have no difference between WT and TTR-/- mice. …”
  18. 1378

    Assessment of calcium events, pERK levels, NMDA receptor expression and extracellular zinc levels in <i>slc13a5</i> mutants. by Deepika Dogra (21072023)

    Published 2025
    “…WT, n = 5; <i>5a</i><sup><i>−/−</i></sup><i>;5b</i><sup><i>−/−</i></sup><i>,</i> n = 6. …”
  19. 1379

    First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation by Kairui Yue (11874403)

    Published 2022
    “…Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC<sub>50</sub> value of 0.019 μM. To our surprise, <b>35m</b> establishes significant improvement in the pharmacokinetic property with much higher AUC<sub>0‑inf</sub> (10292 ng·h/mL) and oral bioavailability (93.4%) than hydroximic acid-based HDAC6 inhibitors Tubastatin A and ACY-1215. …”
  20. 1380

    First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation by Kairui Yue (11874403)

    Published 2022
    “…Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC<sub>50</sub> value of 0.019 μM. To our surprise, <b>35m</b> establishes significant improvement in the pharmacokinetic property with much higher AUC<sub>0‑inf</sub> (10292 ng·h/mL) and oral bioavailability (93.4%) than hydroximic acid-based HDAC6 inhibitors Tubastatin A and ACY-1215. …”